Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
gene therapy - search results
If you're not happy with the results, please do another search
Immersive VR headsets to improve mental health services
£3 million has been funded toward projects generating immersive VR headsets for mental health therapeutics across the UK.
Exploring the possibilities of bacteriophages for tuberculosis
Bacteriophages have long offered prospects for treating bacterial infections. Is it time to use phages to control tuberculosis? Professor Graham F. Hatfull explores this.
Why have HIV outcomes improved with urban gardening?
An urban gardening program has received $3.4 million to reduce food insecurity in the Dominican Republic – and was also found to greatly improve HIV outcomes.
CorTec, neurotechnology and the Brain Interchange System
CorTec's mission is "communicating with the brain - for the cure of disease". By using their Brain Interchange System, they hope to develop stroke rehabilitation.
Professor Richard J. Santen MD – University of Virginia Health System
Dr. Richard Santen, a Professor of Medicine in the Division of Endocrinology at the University of Virginia, maintains an active medical practice with recognition nationally as an outstanding clinical Endocrinologist
He has held several academic positions including Chief of the Division of Endocrinology and Vice Chair of Medicine at the...
Universal receptor system allows customizable immunotherapies for cancer
A universal receptor system that enables T cells to recognize any cell surface target has been created by University of Pittsburgh researchers, which could revolutionise customizable immunotherapies for treating cancer and other diseases.
Could declining muscle function be a sign of dementia?
Edith Cowan University suggests that declining muscle function may indicate a higher risk of late-life dementia.
Neuromyelitis optica (NMO) – on the path to a cure
Dr. Ludivine Herman, Project Leader at immunotherapy specialist Imcyse, walks us through Neuoromyelitis optica facts & trends, the challenges of current therapies and the potential of immunotherapies.
How AI can optimise early cancer treatment
Early cancer treatment is vital to sustaining high cancer survival rates, but could AI improve clinician capabilities and predict worse cases?
What does racial trauma look like, and how is it affecting communities?
Frequent exposure to racism impacts long-term mental health, often influencing ‘racial trauma’, leading to self-hatred and a low sense of self-worth
Across many African American communities in the US, depression and anxiety have been on the rise. Evidence has proven that racism has been a contributing factor to this, creating...
Benefits of swimming and blue spaces on mental health
A new study from Better investigates the benefits of blue spaces and swimming for mental and physical health.
Can cardiac devices be affected by electric vehicles?
High-power electric vehicle chargers could have electromagnetic interference with cardiac devices, which researchers look at with consideration of safety.
Biomedical research and innovation, including autism
Open Access Government provides a short introduction to biomedical research and innovation in the UK, including autism.
Targeting the Cannabinoid Type-2 Receptor for Novel Anto-inflammatory Therapeutics
Type-2 cannabinoid receptor (CB2R) is a G-protein-coupled receptor (GPCR) and an essential element of the endocannabinoid system (ECS) [1].
Social prescribing & building for health in the NHS
We hear from Rhea Horlock, Head of Corporate Social Responsibility at NHS Property Services (NHSPS), who discusses social prescribing & building for health.
Exploring current and future therapies for childhood astrocytoma
Here, Doctor Peter J Houghton explains current therapies for childhood brain cancer what needs to change to ensure better outcomes for children diagnosed with astrocytoma in the future.
Neuronal networks of depression: Pushing the limits of brain stimulation technology
A team of researchers at the University of Freiburg and Delft University of Technology have joined forces to explore a new focused ultrasound technology to tap into the Neuronal Networks of Depression.
Advancements in how we identify and treat hypoxic cancers
Cancers that are starved of oxygen, otherwise known as hypoxic cancers, are generally difficult to identify – but medical imaging has taken a new step with the MR-Linac scanner.
The global regulatory landscape for psychedelic drugs
Jessica Riggleman, Owner of Raeco, LLC, examines the global regulatory landscape for psychedelic drugs, with a particular focus on Schedule I classification.
Jessica Riggleman – Raeco, LLC
Jessica is the owner of Raeco, LLC, a Global Research Consulting Organization for pharmaceuticals and medical devices
She has spent the last ten years in the clinical research industry and has worked closely with cross-functional teams to develop clinical evidence generation strategies for global regulatory submissions.
Jessica has supported and published...
